Christina Todd
Psychiatric/Mental Health · Cape Coral, FLNPI 1659866978
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.7% of the total across 414 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $3,236 and has fallen 88.0% since, to $389 in 2025. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 414 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$1K
- AbbVie$915
- Ironshore Pharmaceuticals Inc.$794
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$765
- Johnson & Johnson$738
- Otsuka America Pharmaceutical, Inc.$721
- plus $3K from 19 others
What the payments were for
- Travel & lodging$7158%
- Food & beverage$7,86992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 5 | $1,389 |
| AbbVie | 51 | $915 |
| Ironshore Pharmaceuticals Inc. | 48 | $794 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 59 | $765 |
| Johnson & Johnson | 38 | $738 |
| Otsuka America Pharmaceutical, Inc. | 38 | $721 |
| Alkermes, Inc. | 24 | $499 |
| Corium, LLC | 23 | $462 |
| Supernus Pharmaceuticals, Inc. | 32 | $443 |
| Sunovion Pharmaceuticals Inc. | 16 | $324 |
| Lundbeck LLC | 12 | $240 |
| Axsome Therapeutics, Inc. | 10 | $223 |
| Teva Pharmaceuticals USA, Inc. | 11 | $195 |
| Tempus AI, Inc | 9 | $174 |
| Almatica Pharma LLC | 10 | $161 |
| Neurocrine Biosciences, Inc. | 5 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Noven Therapeutics, LLC | 5 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $86 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Indivior Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Tris Pharma Inc | 1 | $13 |
| Neos Therapeutics, LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,389
- Azstarys$104
How this compares
$8,583 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Cape Coral
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.